Home » Topics » BioWorld Science

BioWorld Science
RSS

First biologic treatment approved for children with lupus in Europe

Oct. 31, 2019

ACADIA Pharmaceuticals initiates phase III LAVENDER study of trofinetide in Rett syndrome

Oct. 31, 2019

New JAK-2 inhibitors identified at East China University of Science and Technology

Oct. 31, 2019

GlaxoSmithKline Biologicals presents new Toll-like receptor 7/8 agonists

Oct. 31, 2019

FDA approves Vumerity for the treatment of multiple sclerosis

Oct. 31, 2019

First patient dosed in phase II study of novel hepcidin mimetic PTG-300

Oct. 31, 2019

Shandong Luoxin Pharmacy Group and Luoxin Pharmaceutical (Shanghai) patent TLR7 agonists

Oct. 31, 2019

Bayer Pharma describes new kallikrein B inhibitors

Oct. 31, 2019

Cyclin-dependant kinase 7 inhibitors discovered by Lead Discovery Center and Qurient

Oct. 31, 2019

Preclinical evaluation of highly potent caspase-cleavable docetaxel prodrug, MPD-03

Oct. 31, 2019

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.